Soon, many patients might initiate contact with the health system not by speaking with a call center worker or receptionist, ...

“djuvant chemoradiation combined with camrelizumab was well tolerated and yielded significantly improved long-term survival,” the researchers wrote.

Our study highlights a concerning 3-fold increase in obesity-related cancer deaths since 1999,” said study author Faizan Ahmed, MD.

US patients with metastatic urothelial cancer have seen improvements in survival since ICIs and ADCs have entered the market, data suggest.

Amid the growing popularity of cannabis, it is perhaps not surprising that clinicians are increasingly accepting its use among cancer survivors,” the researchers wrote.

The investigative unit, which looks into potential safety issues with drugs, vaccines, medical devices, and other products, has had a retention problem for years. Inspectors leave so often that, even ...

Even before recent layoffs, the FDA’s investigative force struggled to monitor drug-making factories in India and China.

COVID-19 cases are on the rise again across the United States, according to data from the US Centers for Disease Control and Prevention.

Adolescents with cancer and their parents said parents should have access to non-sensitive information in patient portals.

The findings of this case series study show substantial variation in the choice of the TNT regimen and were overall aligned with those reported in clinical trials, suggesting the efficacy of TNT in a ...

The FDA has accepted the supplemental new drug application for decitabine/cedazuridine plus venetoclax to treat adults with AML.

Cancer patients without health insurance have not derived the same benefits from the introduction of ICIs as patients with private insurance.